Key Highlights
•
A new study shows that a single gene, SLC12A6, can cause a wide range of Charcot-Marie-Tooth disease (CMT) symptoms, from mild adult-onset neuropathy to severe childhood-onset disease, depending on the specific genetic variant. This is the first gene found to produce such diverse clinical presentations in CMT, which could help explain why patients with the same diagnosis can have very different experiences and guide the search for personalized treatments.
Source →
•
Researchers found that the APOE ε4 gene, a known risk factor for Alzheimer’s, has a stronger effect on key Alzheimer’s biomarkers in Hispanic/Latino individuals with higher European ancestry compared to those with higher African ancestry. This highlights how genetic background can influence disease risk and progression, emphasizing the need for more diverse research to ensure treatments work for everyone.
Source →
•
A study in rats reveals that a tiny molecule called miR-23b-3p helps control an overactive immune response in a type of blood vessel inflammation (IgAV) by dialing down a key immune sensor called TLR4. Restoring this molecule’s function reduced disease symptoms, pointing to a potential new therapeutic strategy for autoimmune conditions.
Source →
•
A new MRI technique called ultrashort echo time magnetization transfer imaging can be used to monitor subtle changes in ankle cartilage right after long-distance running. This provides a non-invasive way to study how exercise impacts joint health over time, which could help prevent injuries in athletes.
Source →
•
Research on genetic epilepsies finds that early clinical features and patterns seen on brain wave tests (EEG) are linked to a child’s specific genetic cause and their long-term outcome. This connection could help doctors provide more accurate prognoses and tailor treatments sooner after diagnosis.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
